Top Suppliers:I want be here




81-23-2

81-23-2 structure
81-23-2 structure
  • Name: Dehydrocholic acid
  • Chemical Name: 3,7,12-trioxo-5β-cholanic acid
  • CAS Number: 81-23-2
  • Molecular Formula: C24H34O5
  • Molecular Weight: 402.524
  • Catalog: API Digestive system medication Biliary medicine
  • Create Date: 2018-02-06 08:00:00
  • Modify Date: 2024-01-03 10:39:35
  • Dehydrocholic acid is a synthetic bile acid, manufactured by the oxidation of cholic acid. Dehydrocholic acid acts as a hydrocholeretic, increasing bile output to clear increased bile acid load.

Name 3,7,12-trioxo-5β-cholanic acid
Synonyms 3,7,12-trioxo-5β-cholanic acid
EINECS 201-335-7
(5β,20R)-3,7,12-Trioxocholan-24-oic acid
3,7,12-Triketo-5b-cholanic Acid
3,7,12-Trioxo-5b-cholan-24-oic Acid
MFCD00066410
3,7,12-trioxo-5beta-cholanic acid
(5b)-3,7,12-Trioxocholan-24-oic Acid
Cholan-24-oic acid, 3,7,12-trioxo-
3,7,12-Trioxocholan-24-oic acid
Dehydrocholic acid
Cholan-24-oic acid, 3,7,12-trioxo-, (5β,20R)-
Description Dehydrocholic acid is a synthetic bile acid, manufactured by the oxidation of cholic acid. Dehydrocholic acid acts as a hydrocholeretic, increasing bile output to clear increased bile acid load.
Related Catalog
Density 1.2±0.1 g/cm3
Boiling Point 581.5±50.0 °C at 760 mmHg
Melting Point 238-240 °C
Molecular Formula C24H34O5
Molecular Weight 402.524
Flash Point 319.5±26.6 °C
Exact Mass 402.240631
PSA 88.51000
LogP 1.77
Vapour Pressure 0.0±3.5 mmHg at 25°C
Index of Refraction 1.535

CHEMICAL IDENTIFICATION

RTECS NUMBER :
FZ2300000
CHEMICAL NAME :
5-beta-Cholan-24-oic acid, 3,7,12-trioxo-
CAS REGISTRY NUMBER :
81-23-2
BEILSTEIN REFERENCE NO. :
3226734
LAST UPDATED :
199701
DATA ITEMS CITED :
8
MOLECULAR FORMULA :
C24-H34-O5
MOLECULAR WEIGHT :
402.58

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
4 gm/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 116,154,1958
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
750 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,495,1982
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intramuscular
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
1500 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AEPPAE Naunyn-Schmiedeberg's Archiv fuer Experimentelle Pathologie und Pharmakologie. (Berlin, Ger.) V.110-253, 1925-66. For publisher information, see NSAPCC. Volume(issue)/page/year: 222,244,1954
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
3100 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
ARZNAD Arzneimittel-Forschung. Drug Research. (Editio Cantor Verlag, Postfach 1255, W-7960 Aulendorf, Fed. Rep. Ger.) V.1- 1951- Volume(issue)/page/year: 12,857,1962
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1620 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. (Heymans Institute of Pharmacology, De Pintelaan 185, B-9000 Ghent, Belgium) V.4- 1898- Volume(issue)/page/year: 116,154,1958
TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
1492 mg/kg
TOXIC EFFECTS :
Sense Organs and Special Senses (Eye) - lacrimation Lungs, Thorax, or Respiration - respiratory stimulation Gastrointestinal - changes in structure or function of salivary glands
REFERENCE :
JJPAAZ Japanese Journal of Pharmacology. (Japanese Pharmacological Soc., c/o Dept. of Pharmacology, Faculty of Medicine, Kyoto Univ., Sakyo-ku, Kyoto 606, Japan) V.1- 1951- Volume(issue)/page/year: 22,235,1972 *** NIOSH STANDARDS DEVELOPMENT AND SURVEILLANCE DATA *** NIOSH OCCUPATIONAL EXPOSURE SURVEY DATA : NOHS - National Occupational Hazard Survey (1974) NOHS Hazard Code - 80397 No. of Facilities: 68 (estimated) No. of Industries: 1 No. of Occupations: 6 No. of Employees: 2770 (estimated)
Hazard Codes C
Safety Phrases S24/25
RIDADR NONH for all modes of transport
WGK Germany 2
RTECS FZ2300000